DoD Lupus Research, Transformative Vision Development Award
ID: 354482Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/354482
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the Fiscal Year 2024 Lupus Transformative Vision Development Award (TVDA) as part of its Lupus Research Program (LRP). This grant aims to support pilot studies that generate preliminary data and demonstrate feasibility for interventions designed to improve the quality of life for individuals with lupus, particularly focusing on innovative healthcare delivery models and mental health improvements. With an estimated total program funding of $500,000 and the expectation of awarding two grants, applicants must submit a pre-application by July 17, 2024, and a full application by August 6, 2024. For further inquiries, interested parties can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT942524LRPTVDA_GG2.pdf
    The Department of Defense (DOD) is announcing the Fiscal Year 2024 (FY24) Lupus Transformative Vision Development Award (TVDA) as part of the Lupus Research Program (LRP), which aims to improve understanding, prevention, diagnosis, and treatment of lupus. This initial funding opportunity, with an available budget of $10 million, supports research geared towards high-impact interventions that enhance patients' quality of life, particularly for those facing disproportionate health burdens. Key dates for submission include a pre-application deadline of July 17, 2024, and a full application deadline of August 6, 2024. Eligible applicants include extramural and intramural organizations, and the proposed projects must address specific focus areas such as innovative healthcare delivery models and improvement of mental health for individuals with lupus. The application involves a two-step submission process through eBRAP and Grants.gov, requiring detailed project narratives, supporting documentation, and a consumer advocate's involvement in project planning. The selected research teams will undergo peer and programmatic reviews, with funding contingent upon available resources and application merit. Overall, this initiative highlights the government's commitment to advancing lupus research and enhancing care for affected individuals.
    Similar Opportunities
    Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for Clinical Observational (CO) Studies focused on musculoskeletal, rheumatic, and skin diseases, under the grant title PAR-24-036. This grant, which does not allow clinical trials, aims to support observational studies that collect critical data to inform future clinical research, particularly regarding disease symptoms, progression, and participant eligibility, while also exploring telehealth and digital outcomes. The initiative is designed to enhance the rigor of future clinical trials through comprehensive data collection from diverse populations, ultimately improving patient outcomes in affected communities. The grant provides up to $475,000 over four years, with applications opening on February 4, 2024, and funding decisions expected by late 2024. Interested applicants can find more information and guidelines at NIH Grants or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the U.S. Army Medical Research and Development Command (USAMRDC), has announced the FY23-FY27 Broad Agency Announcement (BAA) for Extramural Medical Research, which is open for submissions from October 1, 2022, to September 30, 2027. This opportunity invites innovative research proposals that address critical military medical challenges, particularly in the areas of Military Infectious Diseases, Combat Casualty Care, and Military Operational Medicine, with a focus on enhancing medical practices for both military personnel and civilians. The BAA emphasizes the importance of collaboration with Department of Defense and Department of Veterans Affairs resources and requires adherence to strict submission guidelines via Grants.gov and the electronic Biomedical Research Application Portal (eBRAP). Interested applicants can submit pre-proposals at any time during the five-year period, with full proposals invited based on initial submissions, and should direct inquiries to the CDMRP Help Desk at help@eBRAP.org.
    Fiscal Year (FY) 2026 Department of Defense Multidisciplinary Research Program of the University Research Initiative (MURI) Department of Defense Army
    Dept of the Army -- Materiel Command
    The Department of the Army, through the Army Research Office, is offering a funding opportunity under the Fiscal Year 2026 Multidisciplinary Research Program of the University Research Initiative (MURI) aimed at fostering innovative research relevant to national security. This program invites collaborative proposals exclusively from U.S. institutions of higher education with degree-granting programs in science and engineering, focusing on interdisciplinary studies that promise advancements with military applications. With an estimated total program funding of $170 million over five years, the MURI program will support annual grants of up to $1.5 million, with proposals due by September 5, 2025, and optional white papers due by May 2, 2025. Interested applicants can reach out to Dr. Sue Kase at usarmy.rtp.devcom-arl.mbx.aro-muri@army.mil for further information.
    Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Aging (NIA), is offering a Small Research Grant Program (R03) aimed at fostering the next generation of researchers in Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). This program supports innovative projects that enhance understanding, diagnosis, treatment, and care strategies for AD/ADRD, while also promoting workforce diversity and addressing health disparities in this field. Grants of up to $100,000 for a duration of two years are available, with a total of 12 awards expected for fiscal year 2024, amounting to $1.8 million in funding. Interested applicants must be affiliated with eligible organizations and are encouraged to submit their applications by March 16, 2026, with inquiries directed to grantsinfo@nih.gov for further information.
    Disability and Rehabilitation Research Projects (DRRP) Program: Projects for Translating the Findings and Products of Disability and Rehabilitation Research and Development into Practice
    Administration for Community Living
    The Administration for Community Living (ACL) is offering grants under the Disability and Rehabilitation Research Projects (DRRP) Program, aimed at translating findings from disability and rehabilitation research into practical applications. The initiative seeks to enhance the effectiveness of services authorized under the Rehabilitation Act by generating new knowledge and developing methods that improve health, community living, and employment outcomes for individuals with disabilities, particularly those with the greatest support needs. A total of five grants, each with a budget of up to $250,000 over a 60-month period, will be awarded, with applications due by March 17, 2025. Interested applicants must register with the System for Award Management (SAM) and submit their proposals electronically through Grants.gov, including a detailed project narrative, budget justification, and data management plan. For further inquiries, contact Linda Vo at linda.vo@acl.hhs.gov.
    Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering funding opportunities through the "Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases" program, specifically under the R61 Clinical Trial mechanism. This initiative aims to support short-term exploratory clinical trials that investigate treatments for rheumatic, musculoskeletal, and skin conditions, with a focus on diverse therapeutic approaches. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, and state and local governments, with a maximum budget of $600,000 for a three-year project, not exceeding $300,000 in any single year. Applications must be submitted electronically via Grants.gov, with key deadlines starting from February 4, 2024, and inquiries can be directed to NIH Grants Information at grantsinfo@nih.gov. For more details, visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-24-035.html.
    Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering Exploratory Clinical Trial Grants (R61) to support research in arthritis and musculoskeletal and skin diseases. This funding opportunity aims to facilitate short-term, interventional studies that address critical research questions, particularly those evaluating drug efficacy in rare diseases, without requiring preliminary data. Grants can provide up to $600,000 over three years, with applications due by November 2, 2026. Interested applicants are encouraged to consult with NIH staff during the application process and can find additional information at NIH Grants or by contacting NIH Grants Information at grantsinfo@nih.gov.
    NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for the NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3), aimed at supporting interventional clinical trials focused on rheumatic, musculoskeletal, and skin diseases. This initiative encompasses a two-phase approach, where the UG3 phase involves trial preparation and the UH3 phase focuses on trial execution, contingent upon meeting specific milestones. The program emphasizes the importance of developing clinical protocols, obtaining IRB approval, and securing necessary resources, while also promoting health equity by engaging individuals with lived experience in the research process. Interested applicants can apply for funding up to $250,000 for the UG3 phase, with a closing date for submissions set for March 4, 2027. For further inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-24-208.html.
    Department of Defense HIV/AIDS Prevention Program
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering a federal grant opportunity titled the Department of Defense HIV/AIDS Prevention Program (DHAPP). This program aims to save lives and prevent HIV infections by supporting the development of interventions and programs within military health systems, particularly in foreign countries, to achieve HIV/AIDS epidemic control. The DHAPP focuses on enhancing military capacity for ownership and behavioral change, aligning with national strategies, and ensuring sustainable HIV prevention and treatment services. Interested applicants can reach out to Ebony Simmons at ebony.s.simmons.civ@health.mil or by phone at 301-619-2105 for further information. The application deadline is September 18, 2027, with an expected seven awards to be made under this cooperative agreement, which does not require cost sharing or matching.
    Grants for Adaptive Sports Programs for Disabled Veterans and Members of the Armed Forces program
    National Veterans Sports Programs
    The National Veterans Sports Programs is forecasting a grant opportunity titled "Grants for Adaptive Sports Programs for Disabled Veterans and Members of the Armed Forces." This program aims to provide funding to eligible non-Federal entities with significant experience in managing large-scale adaptive sports programs, specifically designed for veterans and members of the Armed Forces with disabilities. The initiative emphasizes the importance of adaptive sports activities, including instruction, competition, and training, to enhance the quality of life for participants. Up to $11 million is available for grants, with an award ceiling of $750,000, and approximately 75 awards expected to be made. Interested applicants can reach out to Vanietta Armstrong at Grants4Vets@va.gov for more information, with proposals due by March 24, 2025, and project start dates anticipated for October 1, 2025.